X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
P/FCF Ratio Over TimeContracting
Percentile Rank30
Studio
Year-over-Year Change

Price to free cash flow ratio

Latest
-1.98
↓ 45% vs avg
Percentile
P30
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-1.36
Historical baseline
PeriodValueYoY Change
2025-1.98-75.8%
2024-1.12+27.2%
2023-1.54-94.1%
2022-0.80-11.7%
2021-0.71+66.8%
2020-2.15+15.2%
2019-2.53-1667.9%
2018-0.14+87.1%
2017-1.11+28.2%
2016-1.54-